e-Article
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial
Document Type
Article
Author
Lasocki, Sigismond; Capdevila, Xavier; Vielle, Bruno; Bijok, Benjamin; Lahlou-Casulli, Maria; Collange, Vincent; Grillot, Nicolas; Danguy des Deserts, Marc; Duchalais, Alexis; Delannoy, Bertrand; Drugeon, Bertrand; Bouzat, Pierre; David, Jean-Stéphane; Rony, Louis; Loupec, Thibault; Léger, Maxime; Rineau, Emmanuel; Bouhours, Guillaume; Lasocki, Sigismond; Lebail, Adeline; Léger, Maxime; Parot-Schinkel, Elsa; Rineau, Emmanuel; Rony, Louis; Vielle, Bruno; Capdevilla, Xavier; Loupec, Thibault; Mounet, Benjamin; Swisser, Fabien; Danguy des Deserts, Marc; Cinotti, Raphael; Grillot, Nicolas; Asehnoune, Karim; Roquilly, Antoine; Beloeil, Hélène; Lahlou-Casulli, Maria; Collange, Vincent; Parent, Sébastien; Delannoy, Bertrand; Desebbe, Olivier; Duchalais, Alexis; Drugeon, Bertrand; Guenezan, Jeremy; Bouzat, Pierre; Drevet, Sabine; Gavazzi, Gaetan; Greze, Jules; Bijok, Benjamin; Garrigue, Delphine; David, Jean-Stéphane
Source
The Lancet Haematology; September 2023, Vol. 10 Issue: 9 pe747-e755, 9p
Subject
Language
ISSN
23523026
Abstract
Anaemia and blood transfusion are associated with poor outcomes after hip fracture. We evaluated the efficacy of intravenous iron and tranexamic acid in reducing blood transfusions after hip fracture surgery.